SunBio,Inc. (KOSDAQ:067370)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Bio-pharmaceuticals, Biosimilars, and Medical Devices	6.40B
Bio-pharmaceuticals, Biosimilars, and Medical Devices Growth	-25.52%
Royalty Income	2.28B
Royalty Income Growth	-38.32%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
India	8.20B
India Growth	-30.12%
United States	264.58M
United States Growth	29.81%
Other Overseas	160.73M
Other Overseas Growth	-47.12%
South Korea	61.66M
South Korea Growth	10.58%